Your browser doesn't support javascript.
loading
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Maio, Michele; Lewis, Karl; Demidov, Lev; Mandalà, Mario; Bondarenko, Igor; Ascierto, Paolo A; Herbert, Christopher; Mackiewicz, Andrzej; Rutkowski, Piotr; Guminski, Alexander; Goodman, Grant R; Simmons, Brian; Ye, Chenglin; Yan, Yibing; Schadendorf, Dirk.
Afiliação
  • Maio M; Division of Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. Electronic address: mmaiocro@gmail.com.
  • Lewis K; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA.
  • Demidov L; N N Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia.
  • Mandalà M; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.
  • Bondarenko I; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine.
  • Ascierto PA; Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
  • Herbert C; Bristol Haematology and Oncology Centre, Bristol, UK.
  • Mackiewicz A; Department of Cancer Immunology, Poznan University for Medical Sciences, Med-POLONIA, Poznan, Poland.
  • Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland.
  • Guminski A; Melanoma Translational Research Group, Melanoma Institute Australia, Wollstonecraft, NSW, Australia.
  • Goodman GR; Genentech, Inc, South San Francisco, CA, USA.
  • Simmons B; Genentech, Inc, South San Francisco, CA, USA.
  • Ye C; Genentech, Inc, South San Francisco, CA, USA.
  • Yan Y; Genentech, Inc, South San Francisco, CA, USA.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany.
Lancet Oncol ; 19(4): 510-520, 2018 04.
Article em En | MEDLINE | ID: mdl-29477665
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Vemurafenib / Ceratoacantoma / Melanoma / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Vemurafenib / Ceratoacantoma / Melanoma / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article